Expert discussion on patient recruitment today now live on 20/20 Pharma
A look at patient recruitment today in this executive interview with Pfizer's Craig Lipset and Dr Rick Malcolm of Acurian, a leading company in the field of patient recruitment.
- New York, NY (1888PressRelease) July 06, 2011 - Industry experts go head to head in 20/20 Pharma's 'Advancing patient recruitment' podcast discussion. Patient recruitment is an essential element to clinical trials and this discussion gives audiences a look at patient recruitment today. The podcast is available to download free at:
http://www.2020pharma.com/podcast/advancing-patient-recruitment
The podcast is moderated by Craig Lipset, Pfizer's Head of Clinical Innovation, Development Operations, Worldwide Research & Development, who is joined by Dr Rick Malcolm, Chief Executive Officer of Acurian.
The podcast is an insightful analysis of patient recruitment and includes comments on:
- The challenges patient recruitment brings to clinical trials
- Myths and misconceptions of patient recruitment
- Opportunities in electronic health data
- E-patients fitting into clinical trials
- Budgeting for patient recruitment
- Forecasting the future of clinical trials.
In the podcast Rick Malcolm said: "Over the years we have sent letters and contacted millions of people about participation in clinical trials and as you know it is highly regulated.
"We have hundreds of thousands of people in the United States that respond to these invitations that have an interest in participating in clinical trials."
He also commented: "On a regular basis, an increasing number of physicians and healthcare systems are doing more and more with electronic health records, which certainly holds out the possibility to be even more targeted in who you reach out to."
For more information and topical pharmaceutical related podcasts visit www.2020pharma.com.
About 20/20 Pharma
20/20 Pharma is a product of IMI Publishing Ltd, dedicated to offering its clients and partners a unique opportunity to not only advertise the capabilities of their companies, but also showcase their technology or services through in-depth educational pieces and targeted online events.
Dedicated to being a trusted and authoritative resource within top pharmaceutical companies, as well as small, specialty and biotech businesses, 20/20 Pharma bridges the gap between the industry's top issues and the solutions that top-tier vendors can provide.
Contact details
Pinar Gencturk
Managing Editor, 20/20 Pharma
+44 207 148 5152 | pgencturk ( @ ) imipublishing dot com
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam